DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Gavin PG, Song N, Kim SR. et al.
Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2-Positive Breast Cancer: Analysis of the NSABP B-31 Trial.
JAMA Oncol 2017;
3: 335-341
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.